Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel S Lee

Showing results (61-70 of 201) with videos related to

Pageof 21
Sort By:
Canadian Liver Journal|August 22, 2022
Achieving HCV micro-elimination in rural communitiesShannon J Brown, Linh T Cosgrove, Samuel S Lee
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 14, 2015
Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot studySamuel S Lee, Leah Kilvert, Hongqun Liu, et al.
Expert Opinion on Pharmacotherapy|April 6, 2013
Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosisMatthew D Sadler, Carla S Coffin, Samuel S Lee
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2017
Cirrhotic cardiomyopathy: Implications for liver transplantationHongqun Liu, Saumya Jayakumar, Mouhieddin Traboulsi, et al.
Canadian Liver Journal|July 28, 2023
The Canadian hepatitis C treatment landscape: Time to turn chaos into orderKienan P Williams, Kate Pr Dunn, Samuel S Lee
The Korean Journal of Hepatology|March 19, 2011
Hemodynamic alterations in cirrhosis and portal hypertensionMoon Young Kim, Soon Koo Baik, Samuel S Lee
Best Practice & Research. Clinical Gastroenterology|January 16, 2007
Cardiac dysfunction in cirrhosisRalph F Lee, Tamara K Glenn, Samuel S Lee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 23, 2007
Impact of pharmaceutical industry versus university sponsorship on survey response: a randomized trial among Canadian hepatitis C care providersRobert P Myers, Abdel Aziz M Shaheen, Samuel S Lee
Gut and Liver|July 22, 2022
Prolonged QT Interval in Cirrhosis: Twisting Time?William Lee, Bert Vandenberk, Satish R Raj, et al.
Current Opinion in Gastroenterology|March 23, 2021
Advances in cirrhotic cardiomyopathyHongqun Liu, Ki Tae Yoon, Jing Zhang, et al.
Pageof 21

Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
Canadian Liver Journal|August 22, 2022
Achieving HCV micro-elimination in rural communitiesShannon J Brown, Linh T Cosgrove, Samuel S Lee
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 14, 2015
Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot studySamuel S Lee, Leah Kilvert, Hongqun Liu, et al.
Expert Opinion on Pharmacotherapy|April 6, 2013
Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosisMatthew D Sadler, Carla S Coffin, Samuel S Lee
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2017
Cirrhotic cardiomyopathy: Implications for liver transplantationHongqun Liu, Saumya Jayakumar, Mouhieddin Traboulsi, et al.
Canadian Liver Journal|July 28, 2023
The Canadian hepatitis C treatment landscape: Time to turn chaos into orderKienan P Williams, Kate Pr Dunn, Samuel S Lee
The Korean Journal of Hepatology|March 19, 2011
Hemodynamic alterations in cirrhosis and portal hypertensionMoon Young Kim, Soon Koo Baik, Samuel S Lee
Best Practice & Research. Clinical Gastroenterology|January 16, 2007
Cardiac dysfunction in cirrhosisRalph F Lee, Tamara K Glenn, Samuel S Lee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 23, 2007
Impact of pharmaceutical industry versus university sponsorship on survey response: a randomized trial among Canadian hepatitis C care providersRobert P Myers, Abdel Aziz M Shaheen, Samuel S Lee
Gut and Liver|July 22, 2022
Prolonged QT Interval in Cirrhosis: Twisting Time?William Lee, Bert Vandenberk, Satish R Raj, et al.
Current Opinion in Gastroenterology|March 23, 2021
Advances in cirrhotic cardiomyopathyHongqun Liu, Ki Tae Yoon, Jing Zhang, et al.
Pageof 21